Diseases
Breakthrough in Immunology: Development of CNS-Tau-Specific Antibodies
Researchers at Brigham and Women's Hospital have made a significant discovery in the field of immunology, developing two CNS-tau-specific monoclonal antibodies that can be used to diagnose and understand the progression of tau-related neurodegenerative diseases such as Alzheimer's disease. The antibodies, LL-T-1-1 and LL-T-1-5, were created